US Stock MarketDetailed Quotes

OMGA Omega Therapeutics

Watchlist

2.270
-0.080-3.40%

Close Apr 26 16:00 ET

2.289
+0.019+0.85%

Post 18:47 ET

125.20MMarket Cap-1261P/E (TTM)

Omega Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

49.25%3.09M

34.56%989K

39.66%831K

59.45%759K

92.54%516K

1,339.58%2.07M

410.42%735K

595K

476K

268K

Operating revenue

49.25%3.09M

34.56%989K

39.66%831K

59.45%759K

92.54%516K

1,339.58%2.07M

410.42%735K

--595K

--476K

--268K

Cost of revenue

Gross profit

Operating expense

-1.42%103.36M

-31.59%21.69M

-10.71%23.73M

20.01%31.6M

30.19%26.33M

58.42%104.84M

52.35%31.7M

54.35%26.58M

73.17%26.33M

56.29%20.23M

Selling and administrative expenses

10.62%26.19M

-14.57%6.16M

51.39%7.87M

0.06%6.21M

10.14%5.95M

42.58%23.67M

26.60%7.21M

16.57%5.2M

70.53%6.2M

96.94%5.41M

-General and administrative expense

10.62%26.19M

-14.57%6.16M

51.39%7.87M

0.06%6.21M

10.14%5.95M

42.58%23.67M

26.60%7.21M

16.57%5.2M

70.53%6.2M

96.94%5.41M

Research and development costs

-4.93%77.17M

-41.44%15.72M

-20.30%16.48M

29.01%25.01M

40.71%19.97M

69.57%81.17M

83.28%26.84M

68.20%20.67M

73.35%19.39M

45.58%14.19M

Other operating expenses

----

-185.67%-610K

-48.58%381K

-34.60%412K

----

50.53%712K

92.97%741K

40.31%630K

Operating profit

2.44%-100.26M

33.16%-20.7M

11.86%-22.9M

-19.29%-30.84M

-29.36%-25.82M

-55.63%-102.77M

-49.86%-30.97M

-50.89%-25.99M

-70.04%-25.85M

-54.22%-19.96M

Net non-operating interest income expense

1,165.77%2.81M

96.37%487K

271.74%684K

1,840.00%957K

540.00%682K

124.40%222K

246.75%248K

154.28%184K

71.05%-55K

26.89%-155K

Non-operating interest income

1,165.77%2.81M

----

--222K

----

Total other finance cost

----

-271.74%-684K

-1,840.00%-957K

-540.00%-682K

----

-154.28%-184K

--55K

--155K

Other net income (expense)

114.65%23K

98.13%-2K

-1,550.00%-29K

6,633.33%196K

-186.00%-143K

88.27%-157K

-409.52%-107K

100.21%2K

80.00%-3K

85.03%-50K

Other non- operating income (expenses)

114.65%23K

98.13%-2K

-1,550.00%-29K

6,633.33%196K

-186.00%-143K

-460.71%-157K

-409.52%-107K

0.00%2K

25.00%-3K

-1,150.00%-50K

Income before tax

5.13%-97.43M

34.43%-20.21M

13.76%-22.25M

-14.57%-29.69M

-25.37%-25.28M

-50.41%-102.7M

-47.82%-30.83M

-39.24%-25.8M

-68.15%-25.91M

-49.50%-20.16M

Income tax

Net income

5.13%-97.43M

34.43%-20.21M

13.76%-22.25M

-14.57%-29.69M

-25.37%-25.28M

-50.41%-102.7M

-47.82%-30.83M

-39.24%-25.8M

-68.15%-25.91M

-49.50%-20.16M

Net income continuous Operations

5.13%-97.43M

34.43%-20.21M

13.76%-22.25M

-14.57%-29.69M

-25.37%-25.28M

-50.41%-102.7M

-47.82%-30.83M

-39.24%-25.8M

-68.15%-25.91M

-49.50%-20.16M

Minority interest income

Net income attributable to the parent company

5.13%-97.43M

34.43%-20.21M

13.76%-22.25M

-14.57%-29.69M

-25.37%-25.28M

-50.41%-102.7M

-47.82%-30.83M

-39.24%-25.8M

-68.15%-25.91M

-49.50%-20.16M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

5.13%-97.43M

34.43%-20.21M

13.76%-22.25M

-14.57%-29.69M

-25.37%-25.28M

-50.41%-102.7M

-47.82%-30.83M

-39.24%-25.8M

-68.15%-25.91M

-49.50%-20.16M

Basic earnings per share

15.89%-1.8

43.75%-0.36

25.93%-0.4

0.00%-0.54

-19.05%-0.5

29.84%-2.14

-45.45%-0.64

5.26%-0.54

-63.74%-0.54

3.08%-0.42

Diluted earnings per share

15.89%-1.8

43.75%-0.36

25.93%-0.4

0.00%-0.54

-19.05%-0.5

29.84%-2.14

-45.45%-0.64

5.26%-0.54

-63.74%-0.54

3.08%-0.42

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	49.25%3.09M	34.56%989K	39.66%831K	59.45%759K	92.54%516K	1,339.58%2.07M	410.42%735K	595K	476K	268K
Operating revenue	49.25%3.09M	34.56%989K	39.66%831K	59.45%759K	92.54%516K	1,339.58%2.07M	410.42%735K	--595K	--476K	--268K
Cost of revenue
Gross profit
Operating expense	-1.42%103.36M	-31.59%21.69M	-10.71%23.73M	20.01%31.6M	30.19%26.33M	58.42%104.84M	52.35%31.7M	54.35%26.58M	73.17%26.33M	56.29%20.23M
Selling and administrative expenses	10.62%26.19M	-14.57%6.16M	51.39%7.87M	0.06%6.21M	10.14%5.95M	42.58%23.67M	26.60%7.21M	16.57%5.2M	70.53%6.2M	96.94%5.41M
-General and administrative expense	10.62%26.19M	-14.57%6.16M	51.39%7.87M	0.06%6.21M	10.14%5.95M	42.58%23.67M	26.60%7.21M	16.57%5.2M	70.53%6.2M	96.94%5.41M
Research and development costs	-4.93%77.17M	-41.44%15.72M	-20.30%16.48M	29.01%25.01M	40.71%19.97M	69.57%81.17M	83.28%26.84M	68.20%20.67M	73.35%19.39M	45.58%14.19M
Other operating expenses	----	----	-185.67%-610K	-48.58%381K	-34.60%412K	----	----	50.53%712K	92.97%741K	40.31%630K
Operating profit	2.44%-100.26M	33.16%-20.7M	11.86%-22.9M	-19.29%-30.84M	-29.36%-25.82M	-55.63%-102.77M	-49.86%-30.97M	-50.89%-25.99M	-70.04%-25.85M	-54.22%-19.96M
Net non-operating interest income expense	1,165.77%2.81M	96.37%487K	271.74%684K	1,840.00%957K	540.00%682K	124.40%222K	246.75%248K	154.28%184K	71.05%-55K	26.89%-155K
Non-operating interest income	1,165.77%2.81M	----	----	----	----	--222K	----	----	----	----
Total other finance cost	----	----	-271.74%-684K	-1,840.00%-957K	-540.00%-682K	----	----	-154.28%-184K	--55K	--155K
Other net income (expense)	114.65%23K	98.13%-2K	-1,550.00%-29K	6,633.33%196K	-186.00%-143K	88.27%-157K	-409.52%-107K	100.21%2K	80.00%-3K	85.03%-50K
Other non- operating income (expenses)	114.65%23K	98.13%-2K	-1,550.00%-29K	6,633.33%196K	-186.00%-143K	-460.71%-157K	-409.52%-107K	0.00%2K	25.00%-3K	-1,150.00%-50K
Income before tax	5.13%-97.43M	34.43%-20.21M	13.76%-22.25M	-14.57%-29.69M	-25.37%-25.28M	-50.41%-102.7M	-47.82%-30.83M	-39.24%-25.8M	-68.15%-25.91M	-49.50%-20.16M
Income tax
Net income	5.13%-97.43M	34.43%-20.21M	13.76%-22.25M	-14.57%-29.69M	-25.37%-25.28M	-50.41%-102.7M	-47.82%-30.83M	-39.24%-25.8M	-68.15%-25.91M	-49.50%-20.16M
Net income continuous Operations	5.13%-97.43M	34.43%-20.21M	13.76%-22.25M	-14.57%-29.69M	-25.37%-25.28M	-50.41%-102.7M	-47.82%-30.83M	-39.24%-25.8M	-68.15%-25.91M	-49.50%-20.16M
Minority interest income
Net income attributable to the parent company	5.13%-97.43M	34.43%-20.21M	13.76%-22.25M	-14.57%-29.69M	-25.37%-25.28M	-50.41%-102.7M	-47.82%-30.83M	-39.24%-25.8M	-68.15%-25.91M	-49.50%-20.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	5.13%-97.43M	34.43%-20.21M	13.76%-22.25M	-14.57%-29.69M	-25.37%-25.28M	-50.41%-102.7M	-47.82%-30.83M	-39.24%-25.8M	-68.15%-25.91M	-49.50%-20.16M
Basic earnings per share	15.89%-1.8	43.75%-0.36	25.93%-0.4	0.00%-0.54	-19.05%-0.5	29.84%-2.14	-45.45%-0.64	5.26%-0.54	-63.74%-0.54	3.08%-0.42
Diluted earnings per share	15.89%-1.8	43.75%-0.36	25.93%-0.4	0.00%-0.54	-19.05%-0.5	29.84%-2.14	-45.45%-0.64	5.26%-0.54	-63.74%-0.54	3.08%-0.42
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall